Lifecore Biomedical, Inc.

NASDAQ:LFCR

Drug Manufacturers - Specialty & Generic

Healthcare
$6.40 +0.27%

+$0.02 today

Market cap
$242.60M
Beta
1.07
P/E (TTM)
-6.1
EPS (TTM)
-$0.91
52W Low $3.63High $8.98

Volume 0.15M

Average 0.29M

LFCR Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Lifecore Biomedical, Inc.NASDAQ: LFCR

Weighted Avg Shares (Diluted) · Q3 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) of 37.48M shares in Q3 FY2026

Q3 FY2026 weighted avg shares (diluted) was 37.48M shares. Trailing-twelve-month weighted avg shares (diluted) was 37.34M shares. Over 3 fiscal years it compounded at +5.7% a year.

Context

  • Weighted avg shares (diluted) increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly weighted avg shares (diluted) holds near 37.48M shares or moves back toward the trailing-twelve-month quarterly average of 9.34M shares.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
37.48M+0.0% QoQ
Last fiscal yearMay 2025
34.82M-5.0% YoY
LTMMar 2026
37.34M— YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year-5.0%——
3-year CAGR+5.7%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
34.82M USD
Year-over-year change
-5.0%
4-year CAGR
+4.4%

Weighted Avg Shares (Diluted) vs competitors

How LFCR compares with its peers on the latest reported figures

  • LFCR's LTM Mar 2026 weighted avg shares (diluted) of 37.34M shares is the 9th highest of the 10 companies compared; the peer median is 53.53M shares.
  • Over three fiscal years its annual growth of +5.7% compares with a peer median of +19.1%.
LFCR Competitors Peer median
Weighted Avg Shares (Diluted) for LFCR and competitors
Company Period LTM YoY 3-year CAGR
CGCCanopy Growth CorporationLTM Mar 2026298.22M +210.7%+300.6%
IMMPImmutep LimitedFY2025145.58M +21.2%+19.1%
PRQRProQR Therapeutics N.V.LTM Mar 2026105.94M +21.0%+13.7%
ACBAurora Cannabis Inc.LTM Mar 202656.58M +3.1%+20.7%
TKNOAlpha Teknova, Inc.LTM Mar 202653.53M +11.4%+24.0%
SGHTSight Sciences, Inc.LTM Mar 202652.81M +4.4%+2.9%
ACHVAchieve Life Sciences, Inc.LTM Mar 202648.09M +39.5%+60.3%
BIOABioAge Labs, Inc.LTM Mar 202637.57M +7.3%+1.7%
LFCRLifecore Biomedical, Inc.LTM Mar 202637.34M —+5.7%
CVRXCVRx, Inc.LTM Mar 202626.2M +12.8%+8.3%
Peer median (excluding LFCR) 53.53M+12.8%+19.1%

Competitors are the stored peer set for LFCR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
May 2021
FY2022
May 2022
FY2023
May 2023
FY2024
May 2024
FY2025
May 2025
Revenue100.87M111.27M103.27M128.26M128.87M
Cost of Revenue61.94M72.2M75.28M86.41M88.57M
Gross Profit38.94M39.07M27.99M41.85M40.3M
Gross Margin38.6%35.1%27.1%32.6%31.3%
Research & Development6.68M7.84M8.74M8.58M8.26M
Selling, General & Admin27.72M34.66M38.97M40.46M44.05M
Operating Expenses47.76M50.86M49.78M50.69M57.54M
Depreciation & Amortization19.87M18.06M13.18M8M8.03M
EBITDA(987K)12.84M(33.17M)35.6M(8.81M)
EBITDA Margin-1.0%11.5%-32.1%27.8%-6.8%
Operating Income(8.82M)(11.79M)(21.8M)(8.84M)(17.25M)
Operating Margin-8.7%-10.6%-21.1%-6.9%-13.4%
Interest Income48K81K68K00
Interest Expense8.93M15.55M17.65M18.09M21.84M
Other Income / Expenses(20.96M)(8.9M)(42.13M)18.36M(21.43M)
Income Before Tax(29.79M)(20.69M)(63.93M)9.51M(38.67M)
Pre-Tax Margin-29.5%-18.6%-61.9%7.4%-30.0%
Income Tax Expense(6.35M)(5.21M)308K183K43K
Net Income(32.29M)(116.72M)(99.56M)12.01M(38.72M)
Net Margin-32.0%-104.9%-96.4%9.4%-30.0%
EPS (Basic)(1.12)(3.97)(3.32)0.39(1.27)
EPS (Diluted)(1.12)(3.97)(3.32)0.33(1.27)
Weighted Avg Shares29.29M29.47M29.96M30.47M34.82M
Weighted Avg Shares (Diluted)29.29M29.47M29.96M36.66M34.82M

Lifecore Biomedical, Inc.

NASDAQ:LFCR

Intrinsic Alpha fair value

Locked

Current Price

$6.40

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.